The Linkou Chang Gung Memorial Hospital also known as Chang Gung Memorial Hospital or "Chang Gung Hospital", is a hospital located in Guishan District, Taoyuan City, Taiwan. It is part of the Chang Gung Medical Foundation hospital network.

During the past decade, Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 6 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology" #1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology" are "Gastric Cancer" (3 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials), "Non-Hodgkin's Lymphoma" (1 trials) and "Non-Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology" in a lesser frequency.

Most popular intervention types in "Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Obinutuzumab" (3 trials), "Rituximab" (3 trials), "5-Fluorouracil" (2 trials), "Cyclophosphamide" (2 trials) and "Doxorubicin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".